The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo.
The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo.
复制标题
DOI:
10.1371/journal.pone.0007421
复制
发表时间:
2009-10-12
期刊:
影响因子:
3.7
通讯作者:
Bishop-Bailey D
中科院分区:
文献类型:
--
作者:
Wray JA;Sugden MC;Zeldin DC;Greenwood GK;Samsuddin S;Miller-Degraff L;Bradbury JA;Holness MJ;Warner TD;Bishop-Bailey D
Peroxisome proliferator-activated receptors (PPARs) are a family of three (PPARα, -β/δ, and -γ) nuclear receptors. In particular, PPARα is involved in regulation of fatty acid metabolism, cell growth and inflammation. PPARα mediates the cardiac fasting response, increasing fatty acid metabolism, decreasing glucose utilisation, and is the target for the fibrate lipid-lowering class of drugs. However, little is known regarding the endogenous generation of PPAR ligands. CYP2J2 is a lipid metabolising cytochrome P450, which produces anti-inflammatory mediators, and is considered the major epoxygenase in the human heart. Expression of CYP2J2 in vitro results in an activation of PPAR responses with a particular preference for PPARα. The CYP2J2 products 8,9- and 11-12-EET also activate PPARα. In vitro, PPARα activation by its selective ligand induces the PPARα target gene pyruvate dehydrogenase kinase (PDK)4 in cardiac tissue. In vivo, in cardiac-specific CYP2J2 transgenic mice, fasting selectively augments the expression of PDK4. Our results establish that CYP2J2 produces PPARα ligands in vitro and in vivo, and suggests that lipid metabolising CYPs are prime candidates for the integration of global lipid changes to transcriptional signalling events.
登录
查看更多内容
影响因子:
15.9
作者:
Djouadi, F;Weinheimer, CJ;Kelly, DP
通讯作者:
Kelly, DP
影响因子:
3.9
作者:
Spiecker, M;Liao, JK
通讯作者:
Liao, JK
影响因子:
11.2
作者:
Swales, Karen E.;Korbonits, Marta;Bishop-Bailey, David
通讯作者:
Bishop-Bailey, David
影响因子:
4.8
作者:
Cowart, LA;Wei, SZ;Capdevila, JH
通讯作者:
Capdevila, JH
影响因子:
4.8
作者:
Athirakul, Krairerk;Bradbury, J. Alyce;Zeldin, Darryl C.
通讯作者:
Zeldin, Darryl C.